Kehua Biological: Announcement on the suspension of share conversion of "Kehua Convertible Bonds" during the sale period
Securities code: 002022 Securities abbreviation: Kehua Biotech
Announcement Number: 2025-049 Bond Code: 128124 Bond Abbreviation: Kehua Convertible Bonds
Shanghai Kehua Bioengineering Co., Ltd.
Announcement on the suspension of share conversion of "Kehua Convertible Bonds" during the sale period
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Special tips:
Bond code: 128124, bond abbreviation: Kehua Convertible Bonds
The start and end time of the share transfer: February 3, 2021 to July 27, 2026
Suspension of share conversion: September 10, 2025 to September 16, 2025
Time to resume share conversion: September 17, 2025
As approved by the China Securities Regulatory Commission's "Zhengjian Xu [2020] No. 970" document, Shanghai Kehua Bioengineering Co., Ltd. (hereinafter referred to as the "Company") publicly issued 7.38 million convertible corporate bonds on July 28, 2020, with a face value of 100 yuan each, with a total issuance of 738 million yuan, and a term of 6 years. With the consent of the Shenzhen Stock Exchange's "Shenzhen Zhengshang [2020] No. 731" document, the company's 738 million yuan convertible bonds will be listed for trading on the Shenzhen Stock Exchange on August 20, 2020. The bond's abbreviation is "Kehua Convertible Bonds" and the bond code is "128124". "Kehua Convertible Bonds" can be converted into company shares starting from February 3, 2021, and the "Kehua Convertible Bonds" are currently in the conversion period.
The closing price of the company's stock for 30 consecutive trading days from July 28, 2025 to September 5, 2025 was lower than 70% of the current conversion price of 20.64 yuan/share (i.e. 14.45 yuan/share), and the "Kehua Convertible Bonds" are in the last two interest-bearing years. According to the provisions of the Prospectus for the Public Issuance of Convertible Corporate Bonds by Shanghai Kehua Bioengineering Co., Ltd., the conditional sell-back clause of the "Kehua Convertible Bonds" came into effect. For details, please refer to the "Announcement on the Sale Back of "Kehua Convertible Bonds" disclosed by the company on the same day (Announcement No.: 2025-048).
According to the relevant provisions of the Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 15 - Convertible Corporate Bonds, if convertible corporate bonds are sold back, the conversion of convertible corporate bonds shall be suspended. After applying to the Shenzhen Stock Exchange, the conversion of "Kehua Convertible Bonds" will be suspended during the sale-back declaration period, that is, the conversion will be suspended starting from September 10, 2025 (Wednesday), and the suspension period will be five trading days until September 16, 2025 (Tuesday). The conversion of "Kehua Convertible Bonds" will resume from the trading day after the end of the sell-back declaration period (i.e. September 17, 2025). During the above-mentioned suspension of conversion period, the company's convertible corporate bonds will be traded normally. holders of the company's convertible corporate bonds are kindly advised to pay attention.
Announcement is hereby made.
Board of Directors of Shanghai Kehua Bioengineering Co., Ltd.
September 8, 2025